285
Views
21
CrossRef citations to date
0
Altmetric
Review

Thiomers and their potential applications in drug delivery

ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon ORCID Icon
Pages 601-610 | Received 17 Jun 2016, Accepted 15 Aug 2016, Published online: 06 Sep 2016

References

  • Gyarmati B, Némethy Á, Szilágyi A. Reversible disulphide formation in polymer networks: a versatile functional group from synthesis to applications. Eur Polym J. 2013;49:1268–1286.
  • Bacalocostantis I, Mane VP, Kang MS, et al. Effect of thiol pendant conjugates on plasmid DNA binding, release, and stability of polymeric delivery vectors. Biomacromolecules. 2012;13:1331–1339.
  • Gyarmati B, Krisch E, Szilágyi A. In situ oxidation-induced gelation of poly(aspartic acid) thiomers. React Funct Polym. 2014;84:29–36.
  • Samuel AJ, Kulkarni M, Tambe R, et al. Thiomers: forms, features and formulations. J Chem Pharm Res. 2010;2:316–323.
  • Li C, Guo T, Zhou D, et al. A novel glutathione modified chitosan conjugate for efficient gene delivery. J Controlled Release. 2011;154:177–188.
  • Jin X, Xu Y, Shen J, et al. Chitosan–glutathione conjugate-coated poly(butyl cyanoacrylate) nanoparticles: promising carriers for oral thymopentin delivery. Carbohydr Polym. 2011;86:51–57.
  • Bernkop-Schnürch DA, Greimel A. Thiomers. Am J Drug Deliv. 2005;3:141–154.
  • Laffleur F, Bernkop-Schnürch A. Thiomers: promising platform for macromolecular drug delivery. Future Med Chem. 2012;4:2205–2216.
  • Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56:1649–1659.
  • Balenga NAB, Zahedifard F, Weiss R, et al. Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy. J Biotechnol. 2006;124:602–614.
  • Kafedjiiski K, Jetti RK, Foger F, et al. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery. Int J Pharm. 2007;343:48–58.
  • Shen J, Wang Y, Ping Q, et al. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Controlled Release. 2009;137:217–223.
  • Cuenca AG, Jiang H, Hochwald SN, et al. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer. 2006;107:459–466.
  • Laffleur F, Bernkop-Schnürch A. Strategies for improving mucosal drug delivery. Nanomedicine. 2013;8:2061–2075.
  • Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161–177.
  • Bhattarai N, Gunn J, Zhang M. Chitosan-based hydrogels for controlled, localized drug delivery☆. Adv Drug Deliv Rev. 2010;62:83–99.
  • Langguth P, Hanafy A, Frenzel D, et al. Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound. Drug Dev Ind Pharm. 2008;31:319–329.
  • Kumar R, Sinha VR. Thiomer: a potential carrier for therapeutic delivery. React Funct Polym. 2013;73:1156–1166.
  • Wong HL, Rauth AM, Bendayan R, et al. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm Res. 2006;23:1574–1585.
  • Walsh EG, Adamczyk BE, Chalasani KB, et al. Oral delivery of macromolecules: rationale underpinning gastrointestinal permeation enhancement technology (GIPET®). Ther Deliv. 2011;2:1595–1610.
  • Hauptstein S, Bernkop-Schnürch A. Thiomers and thiomer-based nanoparticles in protein and DNA drug delivery. Expert Opin Drug Deliv. 2012;9:1069–1081.
  • Iqbal J, Shahnaz G, Dünnhaupt S, et al. Preactivated thiomers as mucoadhesive polymers for drug delivery. Biomaterials. 2012;33:1528–1535.
  • Bonengel S, Haupstein S, Perera G, et al. Thiolated and S-protected hydrophobically modified cross-linked poly(acrylic acid) – a new generation of multifunctional polymers. Eur J Pharm Biopharm. 2014;88:390–396.
  • Shah SU, Martinho N, Socha M, et al. Synthesis and characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor. Expert Opin Drug Deliv. 2015;12:1209–1223.
  • Shah SU, Socha M, Fries I, et al. Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines. Drug Deliv. Epub 2015. doi:10.3109/10717544.2015.1122676.
  • Palmberger T, Hombach J, Bernkop-Schnürch A. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir. Int J Pharm. 2008;348:54–60.
  • Bari NK, Fazil M, Hassan MQ, et al. Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder. Int J Biol Macromol. 2015;81:49–59.
  • Laffleur F, Bacher L, Vanicek S, et al. Next generation of buccadhesive excipient: preactivated carboxymethyl cellulose. Int J Pharm. 2016;500:120–127.
  • Nowak J, Laffleur F, Bernkop-Schnürch A. Preactivated hyaluronic acid: a potential mucoadhesive polymer for vaginal delivery. Int J Pharm. 2015;478:383–389.
  • Duggan S, O’Donovan O, Owens E, et al. Synthesis of mucoadhesive thiolated gelatin using a two-step reaction process. Eur J Pharm Biopharm. 2015;91:75–81.
  • Albrecht K, Bernkop-Schnürch A. Thiomers: forms, functions and applications to nanomedicine. Nanomedicine. 2007;2:41–50.
  • Grabovac V, Laffleur F, Bernkop-Schnürch A. Thiomers: influence of molecular mass and thiol group content of poly(acrylic acid) on efflux pump inhibition. Int J Pharm. 2015;493:374–379.
  • Deepak K, Kumar MS, Mahadevan N. Thiolated chitosan: modified advanced generation of mucoadhesive polymers. Int J Recent Adv Pharm Res. 2012;2:31–41.
  • Millotti G, Samberger C, Fröhlich E, et al. Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility. Biomacromolecules. 2009;10:3023–3027.
  • Ijaz M, Bernkop-Schnürch A. Preactivated thiomers: their role in drug delivery. Expert Opin Drug Deliv. 2015;12:1269–1281.
  • Riniker B. Protection of functional groups in peptide synthesis. Metabolism. 1964;13:1032–1042.
  • Kast CE, Bernkop-Schnürch A. Thiolated polymers – thiomers: development and in vitro evaluation of chitosan–thioglycolic acid conjugates. Biomaterials. 2001;22:2345–2352.
  • Bernkop-Schnurch A. Thiolated polymers – thiomers: synthesis and in vitro evaluation of chitosan–2-iminothiolane conjugates. Int J Pharm. 2003;260:229–237.
  • Kafedjiiski K, Krauland AH, Hoffer MH, et al. Synthesis and in vitro evaluation of a novel thiolated chitosan. Biomaterials. 2005;26:819–826.
  • Hanif M, Zaman M, Qureshi S, et al. Thiomers: a blessing to evaluating era of pharmaceuticals. Int J Polym Sci. 2015;2015:1–9.
  • Madgulkar AR, Bhalekar MR, Asgaonkar KD, et al. Synthesis and characterization of a novel mucoadhesive derivative of xyloglucan. Carbohydr Polym. 2016;135:356–362.
  • Bhalekar MR, Bargaje RV, Upadhaya PG, et al. Formulation of mucoadhesive gastric retentive drug delivery using thiolated xyloglucan. Carbohydr Polym. 2016;136:537–542.
  • Rahmat D, Sakloetsakun D, Shahnaz G, et al. Design and synthesis of a novel cationic thiolated polymer. Int J Pharm. 2011;411:10–17.
  • Sarti F, Staaf A, Sakloetsakun D, et al. Thiolated hydroxyethylcellulose: synthesis and in vitro evaluation. Eur J Pharm Biopharm. 2010;76:421–427.
  • Dünnhaupt S, Barthelmes J, Thurner CC, et al. S-protected thiolated chitosan: synthesis and in vitro characterization. Carbohydr Polym. 2012;90:765–772.
  • Hintzen F, Hauptstein S, Perera G, et al. Synthesis and in vitro characterization of entirely S-protected thiolated pectin for drug delivery. Eur J Pharm Biopharm. 2013;85:1266–1273.
  • Hauptstein S, Müller C, Dünnhaupt S, et al. Preactivated thiomers: evaluation of gastroretentive minitablets. Int J Pharm. 2013;456:473–479.
  • Menzel C, Bonengel S, de Sousa IP, et al. Preactivated thiolated nanoparticles: a novel mucoadhesive dosage form. Int J Pharm. 2016;497:123–128.
  • Menzel C, Silbernagl J, Laffleur F, et al. 2,2ʹDithiodinicotinyl ligands: key to more reactive thiomers. Int J Pharm. 2016;503:199–206.
  • Partenhauser A, Zupančič O, Podričnik S, et al. Entirely S-protected silicone oil as second generation mucoadhesive agent. Eur Polym J. 2016;76:53–62.
  • Katsumi H, Nishikawa M, Yamashita F, et al. Development of polyethylene glycol-conjugated poly-S-nitrosated serum albumin, a novel S-nitrosothiol for prolonged delivery of nitric oxide in the blood circulation in vivo. J Pharmacol Exp Ther. 2005;314:1117–1124.
  • Bernkop-Schnürch A, Krauland AH, Leitner VM, et al. Thiomers: potential excipients for non-invasive peptide delivery systems. Eur J Pharm Biopharm. 2004;58:253–263.
  • Laffleur F, Shahnaz G, Islambulchilar Z, et al. Design and in vitro evaluation of a novel polymeric excipient for buccal applications. Future Med Chem. 2013;5:511–522.
  • Laffleur F, Röggla J, Idrees MA, et al. Chemical modification of hyaluronic acid for intraoral application. J Pharm Sci. 2014;103:2414–2423.
  • Bernkop-Schnürch A, Clausen A. Biomembrane permeability of peptides: strategies to improve their mucosal uptake. Mini Rev Med Chem. 2002;2:295–305.
  • Lee VHL. Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J Controlled Release. 1990;13:213–223.
  • Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23:3–25.
  • Huang W, Lee SL, Yu LX. Mechanistic approaches to predicting oral drug absorption. AAPS J. 2009;11:217–224.
  • Blanquet S, Zeijdner E, Beyssac E, et al. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions. Pharm Res. 2004;21:585–591.
  • Simon DB, Lu Y, Choate KA, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science. 1999;285:103–106.
  • Sreenivas SA, Pai KV. Thiolated chitosans: novel polymers for mucoadhesive drug delivery – a review. Trop J Pharm Res. 2008;7:1077–1088.
  • Kast CE, Bernkop-Schnurch A. Influence of the molecular mass on the permeation enhancing effect of different poly(acrylates). STP Pharm Sci. 2002;12:351–356.
  • Clausen AE, Bernkop-Schnürch A. In vitro evaluation of the permeation‐enhancing effect of thiolated polycarbophil. J Pharm Sci. 2000;89:1253–1261.
  • Bernkop-Schnürch A, Guggi D, Pinter Y. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release. 2004;94:177–186.
  • Clausen AE, Bernkop-Schnurch A. In vitro evaluation of matrix tablets based on thiolated polycarbophil. Pharm Ind. 2001;63:312–317.
  • Wang X, Iqbal J, Rahmat D, et al. Preactivated thiomers: permeation enhancing properties. Int J Pharm 2012;438:217–224.
  • Mahmood A, Bonengel S, Laffleur F, et al. An in-vitro exploration of permeation enhancement by novel polysulfonate thiomers. Int J Pharm. 2015;496:304–313.
  • Vetter A, Bernkop-Schnurch A. Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system. J Drug Target. 2010;18:303–312.
  • Werle M. Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm Res. 2007;25:500–511.
  • Silverman JA. Multidrug-resistance transporters. In: Amidon GL, Sadée W, editors. Membrane transporters as drug targets. Boston (MA): Springer US; 2002. p. 353–386.
  • Hugger ED, Audus KL, Borchardt RT. Effects of poly(ethylene glycol) on efflux transporter activity in Caco‐2 cell monolayers. J Pharm Sci. 2002;91:1980–1990.
  • Kabanov AV, Batrakova EV, Miller DW. Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier. Adv Drug Deliv Rev. 2003;55:151–164.
  • Jha S, Karnani N, Lynn AM, et al. Covalent modification of cysteine 193 impairs ATPase function of nucleotide-binding domain of a Candida drug efflux pump. Biochem Biophys Res Commun. 2003;310:869–875.
  • Palmberger TF, Laffleur F, Greindl M, et al. In vivo evaluation of anionic thiolated polymers as oral delivery systems for efflux pump inhibition. Int J Pharm. 2015;491:318–322.
  • Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci. 1998;6:105–112.
  • Bromberg LE. Enhanced nasal retention of hydrophobically modified polyelectrolytes. J Pharm Pharmacol. 2001;53:109–114.
  • Wei G, Xu H, Ding PT, et al. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release. 2002;83:65–74.
  • Gurny R, Ibrahim H, Buri P. The development and use of in situ formed gels, triggered by pH. In: Edman P, editor. Biopharmaceutics of ocular drug delivery. Boca Raton (FL): CRC Press; 1993. p. 33–58.
  • Chenite A, Chaput C, Wang D, et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials. 2000;21:2155–2161.
  • Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release. 2001;73:205–211.
  • Deasy PB, Quigley KJ. Rheological evaluation of deacetylated gellan gum (Gelrite) for pharmaceutical use. Int J Pharm. 1991;73:117–123.
  • Paulsson M, Hägerström H, Edsman K. Rheological studies of the gelation of deacetylated gellan gum (Gelrite®) in physiological conditions. Eur J Pharm Sci. 1999;9:99–105.
  • Susan MABH, Kaneko T, Noda A, et al. Ion gels prepared by in situ radical polymerization of vinyl monomers in an ionic liquid and their characterization as polymer electrolytes. J Am Chem Soc. 2005;127:4976–4983.
  • Sakloetsakun D, Hombach JM, Bernkop-Schnurch A. In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents. Biomaterials. 2009;30:6151–6157.
  • Hintzen F, Laffleur F, Sakloetsakun D, et al. In situ gelling properties of anionic thiomers. Drug Dev Ind Pharm. 2012;38:1479–1485.
  • Palmberger TF, Albrecht K, Loretz B, et al. Thiolated polymers: evaluation of the influence of the amount of covalently attached l-cysteine to poly(acrylic acid). Eur J Pharm Biopharm. 2007;66:405–412.
  • Friedl HE, Dünnhaupt S, Waldner C, et al. Preactivated thiomers for vaginal drug delivery vehicles. Biomaterials. 2013;34:7811–7818.
  • Sarti F, Iqbal J, Müller C, et al. Poly(acrylic acid)–cysteine for oral vitamin B12 delivery. Anal Biochem. 2012;420:13–19.
  • Hauptstein S, Hintzen F, Müller C, et al. Development and in vitro evaluation of a buccal drug delivery system based on preactivated thiolated pectin. Drug Dev Ind Pharm. 2014;40:1530–1537.
  • Hombach J, Palmberger TF, Bernkop-Schnürch A. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin. J Pharma Sci. 2009;98:555–564.
  • Bernkop-Schnürch A, Scholler S, Biebel RG. Development of controlled drug release systems based on thiolated polymers. J Controlled Release. 2000;66:39–48.
  • Mortazavi SA, Smart JD. Factors influencing gel‐strengthening at the mucoadhesive‐mucus interface. J Pharm Pharmacol. 1994;46:86–90.
  • Coupe AJ, Davis SS, Wilding IR. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res. 1991;8:360–364.
  • Barthelmes J, Dünnhaupt S, Unterhofer S, et al. Thiolated particles as effective intravesical drug delivery systems for treatment of bladder-related diseases. Nanomedicine. 2013;8:65–75.
  • Lee D, Zhang W, Shirley SA, et al. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res. 2007;24:157–167.
  • Hornof M, Weyenberg W, Ludwig A, et al. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. J Control Release. 2003;89:419–428.
  • Wagh MP, Joshi OU, Patel JS, et al. Thiomers: a new generation of mucoadhesive polymers. Res J Pharm Tech. 2009;2:250–255.
  • Zambito Y, Colo GD. Thiolated quaternary ammonium–chitosan conjugates for enhanced precorneal retention, transcorneal permeation and intraocular absorption of dexamethasone. Eur J Pharm Biopharm. 2010;75:194–199.
  • Leitner VM, Guggi D, Krauland AH, et al. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. J Control Release. 2004;100:87–95.
  • Krauland AH, Guggi D, Bernkop-Schnürch A. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery. Int J Pharm. 2006;307:270–277.
  • Shahnaz G, Vetter A, Barthelmes J, et al. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Int J Pharm. 2012;428:164–170.
  • Laffleur F, Dachs S. Development of novel mucoadhesive hyaluronic acid derivate as lubricant for the treatment of dry eye syndrome. Ther Deliv. 2015;6:1211–1219.
  • Sonia TA, Sharma CP. In vitro evaluation of thiolated polydimethylaminoethylmethacrylate hydrogel sub-microparticles for oral insulin delivery. J Biomed Nanotechnol. 2013;9:590–600.
  • Solhi L, Schönbichler SA, Dünnhaupt S, et al. Synthesis and in vitro characterization of a preactivated thiomer via polymerization reaction. Biomacromolecules. 2012;13:3054–3063.
  • Clausen AE, Kast CE, Bernkop‐Schnürch A. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharma Res. 2002;19:602–608.
  • Clausen AE, Bernkop-Schnürch A. Thiolated carboxymethylcellulose: in vitro evaluation of its permeation enhancing effect on peptide drugs. Eur J Pharm Biopharm. 2001;51:25–32.
  • Dunnhaupt S, Barthelmes J, Rahmat D, et al. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Mol Pharm. 2012;9:1331–1341.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.